Claims
- 1. A method for synthesizing an aryl serine comprising the following steps:
- Step A: converting a cinnamate based olefinic substrate to an asymmetric .beta.-hydroxycarbamate product by asymmetric addition of a carbamoyl radical and a hydroxyl radical to the olefinic substrate, the method being of a type which employs a reaction solution which includes a carbamate as a source of the carbamoyl radical, osmium as a catalyst, an anthraquinone based chiral ligand for regioselectively and enantiomerically directing said asymmetric addition, and a solvent having an organic component, the cinnamate based olefinic substrate and carbamate being present and soluble in stoichiometric amounts within the solvent, the osmium being present and soluble in catalytic amounts within the solvent, the anthroquinone (AQN) based chiral ligand being present and soluble within the solvent; and then
- Step B: cleaving the asymmetric .beta.-hydroxycarbamate product of said Step A to produce the aryl serine.
- 2. The method for converting a cinnamate based olefinic substrate to an asymmetric .beta.-hydroxycarbamate product as described in claim 1, wherein, in said Step A, the anthraquinone based chiral ligand is selected from a group consisting of (dihyrodquininyl).sub.2 -AQN and (dihyrodquindinyl).sub.2 -AQN.
- 3. The method for converting a cinnamate based olefinic substrate to an asymmetric .beta.-hydroxycarbamate product as described in claim 2, wherein:
- the organic component of the solvent is selected from the group consisting of acetonitrile, tert-butanol, ethanol, and n-propanol.
- 4. The method for converting a cinnamate based olefinic substrate to an asymmetric .beta.-hydroxycarbamate product as described in claim 3, wherein:
- in said Step A, the aqueous and organic components of the solvent are each approximately 50% on a volume basis.
CROSS-REFERENCE TO RELATED APPLICATION
The instant application is filed as a continuation-in-part of copending U.S. application Ser. No. 08/651,104, filed May 21, 1996.
GOVERNMENT RIGHTS
This invention was made with government support under Grant No. GM 28384 awarded by the National Institutes of Health and Grant No. CHE-9531152 awarded by the National Science Foundation. The U.S. government has certain rights in the invention.
US Referenced Citations (1)
Number |
Name |
Date |
Kind |
5767304 |
Sharpless et al. |
Jun 1998 |
|
Continuation in Parts (1)
|
Number |
Date |
Country |
Parent |
651104 |
May 1996 |
|